Perceptive Medical

Executive Summary

Perceptive Medical is a private medical device company based in San Francisco, focused on cardiovascular solutions. Its flagship product, the BaroHawk™ Vasopressor Management System, has received FDA Breakthrough Device designation for its ability to virtually eliminate low blood pressure during surgery and intensive care. The system leverages proprietary technology to dynamically manage vasopressor delivery, addressing a critical gap in perioperative and critical care. Clinical trials have demonstrated significant efficacy in maintaining hemodynamic stability, reducing the risk of hypotension-related complications. The company's innovation targets a large addressable market, as hypotension is a common and serious issue in operating rooms and ICUs worldwide. With a strong clinical profile and regulatory support, Perceptive Medical is poised to disrupt traditional vasopressor management and improve patient outcomes. The Breakthrough designation provides faster FDA review and enhanced interaction with the agency, accelerating the path to commercial launch. Although the company has not disclosed funding or valuation, its breakthrough status and positive trial data suggest strong potential for growth and market adoption. The management team's experience and the device's clear clinical utility underpin a high conviction in the company's trajectory.

Upcoming Catalysts (preview)

• Q3 2026FDA Pre-Market Approval (PMA) or 510(k) Clearance80% success
• Q2 2026Pivotal Clinical Trial Results Publication90% success
• Q4 2026Commercial Partnership or Distribution Agreement60% success